These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 8620673

  • 1. Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans.
    Awni WM, Hussein Z, Granneman GR, Patterson KJ, Dubé LM, Cavanaugh JH.
    Clin Pharmacokinet; 1995; 29 Suppl 2():67-76. PubMed ID: 8620673
    [Abstract] [Full Text] [Related]

  • 2. Lack of pharmacokinetic interaction between zileuton and phenytoin in humans.
    Samara E, Cavanaugh JH, Mukherjee D, Granneman GR.
    Clin Pharmacokinet; 1995; 29 Suppl 2():84-91. PubMed ID: 8620675
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.
    Awni WM, Braeckman RA, Granneman GR, Witt G, Dubé LM.
    Clin Pharmacokinet; 1995; 29 Suppl 2():22-33. PubMed ID: 8620668
    [Abstract] [Full Text] [Related]

  • 4. Effect of zileuton on theophylline pharmacokinetics.
    Granneman GR, Braeckman RA, Locke CS, Cavanaugh JH, Dubé LM, Awni WM.
    Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic interactions between zileuton and prednisone.
    Awni WM, Cavanaugh JH, Tzeng TB, Witt G, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995; 29 Suppl 2():105-11. PubMed ID: 8620666
    [Abstract] [Full Text] [Related]

  • 6. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M, Almeida L, Falcão A, Soares E, Maia J, Nunes T, Soares-da-Silva P.
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [Abstract] [Full Text] [Related]

  • 7. The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteers.
    Wong SL, Awni WM, Cavanaugh JH, el-Shourbagy T, Locke CS, Dubé LM.
    Clin Pharmacokinet; 1995 Jan; 29 Suppl 2():9-21. PubMed ID: 8620676
    [Abstract] [Full Text] [Related]

  • 8. The effect of food on the pharmacokinetics of zileuton.
    Awni WM, Cavanaugh JH, Witt G, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995 Jan; 29 Suppl 2():62-6. PubMed ID: 8620672
    [Abstract] [Full Text] [Related]

  • 9. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
    Schall R, Müller FO, Hundt HK, Duursema L, Groenewoud G, Middle MV.
    Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
    [Abstract] [Full Text] [Related]

  • 10. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers.
    Awni WM, Braeckman RA, Cavanaugh JH, Locke CS, Linnen PJ, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995 Jan; 29 Suppl 2():112-24. PubMed ID: 8620667
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of zileuton in healthy young and elderly volunteers.
    Braeckman RA, Granneman GR, Locke CS, Machinist JM, Cavannaugh JH, Awni WM.
    Clin Pharmacokinet; 1995 Jan; 29 Suppl 2():42-8. PubMed ID: 8620670
    [Abstract] [Full Text] [Related]

  • 12. The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine.
    Awni WM, Braeckman RA, Locke CS, Dubé LM, Granneman GR.
    Clin Pharmacokinet; 1995 Jan; 29 Suppl 2():98-104. PubMed ID: 8620678
    [Abstract] [Full Text] [Related]

  • 13. Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin.
    Mallikaarjun S, Bramer SL.
    Clin Pharmacokinet; 1999 Jan; 37 Suppl 2():79-86. PubMed ID: 10702890
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans.
    Awni WM, Hussein Z, Cavanaugh JH, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995 Jan; 29 Suppl 2():92-7. PubMed ID: 8620677
    [Abstract] [Full Text] [Related]

  • 15. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.
    Liao S, Palmer M, Fowler C, Nayak RK.
    J Clin Pharmacol; 1996 Nov; 36(11):1072-7. PubMed ID: 8973996
    [Abstract] [Full Text] [Related]

  • 16. Cinacalcet does not affect the pharmacokinetics or pharmacodynamics of warfarin.
    Padhi D, Sullivan JT.
    Drugs R D; 2007 Nov; 8(2):79-87. PubMed ID: 17324005
    [Abstract] [Full Text] [Related]

  • 17. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
    Tiseo PJ, Foley K, Friedhoff LT.
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB, Kell S, Simon M, Vargas R.
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [Abstract] [Full Text] [Related]

  • 19. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.
    Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD.
    J Clin Pharmacol; 1995 Oct; 35(10):1008-15. PubMed ID: 8568008
    [Abstract] [Full Text] [Related]

  • 20. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
    Niopas I, Toon S, Aarons L, Rowland M.
    Eur J Clin Pharmacol; 1999 Jul; 55(5):399-404. PubMed ID: 10456491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.